The blue-chip NSE Nifty 50 index has climbed 11% this month alone, mirroring a global advance in shares, as two sets of promising COVID-19 vaccine trial results boosted hopes of a quicker return to economic growth.
As the Nifty scaled to record levels of near 13,000, a lot of stocks went up. Even valuations were at record levels. However, all this is predicated on the earnings momentum seen in Q2 sustaining.
CNBC-TV18’s Prashant Nair gets an analysis of the earnings expectation that the market has for the next few years.Watch the video for more